Literature DB >> 24095990

[¹²⁵I]AT-1012, a new high affinity radioligand for the α3β4 nicotinic acetylcholine receptors.

Jinhua Wu1, David C Perry2, James E Bupp3, Faming Jiang4, Willma E Polgar3, Lawrence Toll1, Nurulain T Zaveri5.   

Abstract

Recent genetic and pharmacological studies have implicated the α3, β4 and α5 subunits of the nicotinic acetylcholine receptor (nAChR) in dependence to nicotine and other abused drugs and nicotine withdrawal. The α3β4* nAChR subtype has been shown to co-assemble with the α5 or β3 nAChR subunits, and is found mainly in the autonomic ganglia and select brain regions. It has been difficult to study the α3β4 nAChR because there have been no selective nonpeptidic ligands available to independently examine its pharmacology. We recently reported the synthesis of a [(125)I]-radiolabeled analog of a high affinity, selective small-molecule α3β4 nAChR ligand, AT-1012. We report here the vitro characterization of this radioligand in receptor binding and in vitro autoradiographic studies targeting the α3β4* nAChR. Binding of [(125)I]AT-1012 was characterized at the rat α3β4 and α4β2 nAChR transfected into HEK cells, as well as at the human α3β4α5 nAChR in HEK cells. Binding affinity of [(125)I]AT-1012 at the rat α3β4 nAChR was 1.4 nM, with a B(max) of 10.3 pmol/mg protein, similar to what was determined for unlabeled AT-1012 using [(3)H]epibatidine. Saturation isotherms suggested that [(125)I]AT-1012 binds to a single site on the α3β4 nAChR. Similar high binding affinity was also observed for [(125)I]AT-1012 at the human α3β4α5 nAChR transfected into HEK cells. [(125)I]AT-1012 did not bind with high affinity to membranes from α4β2 nAChR-transfected HEK cells. Binding studies with [(3)H]epibatidine further confirmed that AT-1012 had over 100-fold binding selectivity for α3β4 over α4β2 nAChR. K(i) values determined for known nAChR compounds using [(125)I]AT-1012 as radioligand were comparable to those obtained with [(3)H]epibatidine. [(125)I]AT-1012 was also used to label α3β4 nAChR in rat brain slices in vitro using autoradiography, which showed highly localized binding of the radioligand in brain regions consistent with the discreet localization of the α3β4 nAChR. We demonstrate that [(125)I]AT-1012 is an excellent tool for labeling the α3β4 nAChR in the presence of other nAChR subtypes.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AT-1012; Alpha3beta4; In vitro autoradiography; Nicotinic acetylcholine receptor; Receptor binding

Mesh:

Substances:

Year:  2013        PMID: 24095990      PMCID: PMC3866371          DOI: 10.1016/j.neuropharm.2013.09.023

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  31 in total

1.  AT-1001: a high affinity and selective α3β4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats.

Authors:  Lawrence Toll; Nurulain T Zaveri; Willma E Polgar; Faming Jiang; Taline V Khroyan; Wei Zhou; Xinmin Simon Xie; Gregory B Stauber; Matthew R Costello; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2012-01-25       Impact factor: 7.853

2.  18-Methoxycoronaridine acts in the medial habenula and/or interpeduncular nucleus to decrease morphine self-administration in rats.

Authors:  Stanley D Glick; Ruby L Ramirez; Jacklyn M Livi; Isabelle M Maisonneuve
Journal:  Eur J Pharmacol       Date:  2006-03-24       Impact factor: 4.432

3.  Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking.

Authors:  W Berrettini; X Yuan; F Tozzi; K Song; C Francks; H Chilcoat; D Waterworth; P Muglia; V Mooser
Journal:  Mol Psychiatry       Date:  2008-01-29       Impact factor: 15.992

Review 4.  Structural and functional diversity of native brain neuronal nicotinic receptors.

Authors:  Cecilia Gotti; Francesco Clementi; Alice Fornari; Annalisa Gaimarri; Stefania Guiducci; Irene Manfredi; Milena Moretti; Patrizia Pedrazzi; Luca Pucci; Michele Zoli
Journal:  Biochem Pharmacol       Date:  2009-05-27       Impact factor: 5.858

5.  Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence.

Authors:  Scott F Saccone; Nancy L Saccone; Gary E Swan; Pamela A F Madden; Alison M Goate; John P Rice; Laura J Bierut
Journal:  Bioinformatics       Date:  2008-06-19       Impact factor: 6.937

6.  An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants.

Authors:  Christopher G Baddick; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2011-05-10       Impact factor: 5.858

7.  Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit.

Authors:  Ramiro Salas; Fredalina Pieri; Mariella De Biasi
Journal:  J Neurosci       Date:  2004-11-10       Impact factor: 6.167

8.  18-Methoxycoronaridine blocks acquisition but enhances reinstatement of a cocaine place preference.

Authors:  Sarah E McCallum; Stanley D Glick
Journal:  Neurosci Lett       Date:  2009-04-11       Impact factor: 3.046

Review 9.  Human neuronal nicotinic receptors.

Authors:  C Gotti; D Fornasari; F Clementi
Journal:  Prog Neurobiol       Date:  1997-10       Impact factor: 11.685

10.  Rodent habenulo-interpeduncular pathway expresses a large variety of uncommon nAChR subtypes, but only the alpha3beta4* and alpha3beta3beta4* subtypes mediate acetylcholine release.

Authors:  Sharon R Grady; Milena Moretti; Michele Zoli; Michael J Marks; Alessio Zanardi; Luca Pucci; Francesco Clementi; Cecilia Gotti
Journal:  J Neurosci       Date:  2009-02-18       Impact factor: 6.167

View more
  6 in total

1.  Pharmacological stress is required for the anti-alcohol effect of the α3β4* nAChR partial agonist AT-1001.

Authors:  Andrea Cippitelli; Gloria Brunori; Kelly A Gaiolini; Nurulain T Zaveri; Lawrence Toll
Journal:  Neuropharmacology       Date:  2015-02-14       Impact factor: 5.250

2.  The α3β4 nAChR partial agonist AT-1001 attenuates stress-induced reinstatement of nicotine seeking in a rat model of relapse and induces minimal withdrawal in dependent rats.

Authors:  Menglu Yuan; Ariana M Malagon; Dennis Yasuda; James D Belluzzi; Frances M Leslie; Nurulain T Zaveri
Journal:  Behav Brain Res       Date:  2017-07-08       Impact factor: 3.332

3.  Functional characterization of AT-1001, an α3β4 nicotinic acetylcholine receptor ligand, at human α3β4 and α4β2 nAChR.

Authors:  Nurulain T Zaveri; Sonia Bertrand; Dennis Yasuda; Daniel Bertrand
Journal:  Nicotine Tob Res       Date:  2014-09-01       Impact factor: 4.244

4.  AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.

Authors:  Andrea Cippitelli; Jinhua Wu; Kelly A Gaiolini; Daniela Mercatelli; Jennifer Schoch; Michelle Gorman; Alejandra Ramirez; Roberto Ciccocioppo; Taline V Khroyan; Dennis Yasuda; Nurulain T Zaveri; Conrado Pascual; Xinmin Simon Xie; Lawrence Toll
Journal:  Br J Pharmacol       Date:  2015-01-23       Impact factor: 8.739

5.  AT-1001 Is a Partial Agonist with High Affinity and Selectivity at Human and Rat α3β4 Nicotinic Cholinergic Receptors.

Authors:  Edward W Tuan; Andrew G Horti; Thao T Olson; Yongiun Gao; Craig A Stockmeier; Nour Al-Muhtasib; Carrie Bowman Dalley; Amanda E Lewin; Barry B Wolfe; Niaz Sahibzada; Yingxian Xiao; Kenneth J Kellar
Journal:  Mol Pharmacol       Date:  2015-07-10       Impact factor: 4.436

6.  High affinity α3β4 nicotinic acetylcholine receptor ligands AT-1001 and AT-1012 attenuate cocaine-induced conditioned place preference and behavioral sensitization in mice.

Authors:  Taline V Khroyan; Dennis Yasuda; Lawrence Toll; Willma E Polgar; Nurulain T Zaveri
Journal:  Biochem Pharmacol       Date:  2015-08-07       Impact factor: 5.858

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.